Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer

PaperCitations, authors & open-access status

Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 90 citations, 2019 year and hybrid oa status.

90
Citations
2019
Year
hybrid
OA Status

Related on ScholarIQ

Shah‐Jalal Sarker
Author
JAMA Oncology
Journal
PI3K/AKT/mTOR signaling in cancer
Topic
PI3K/AKT/mTOR signaling in cancer
Topic
Advanced Breast Cancer Therapies
Topic
Estrogen and related hormone effects
Topic
470M+ articles · free account